Beone Medicines Ltd.(688235)

277.92+1.09+0.39%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
百济神州有限公司
Industry
医药制造业
Listing Date
2021-12-15
Registered Capital
15万元
Introduction
百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。

1D
5D
Day
Week
Month

Loading ...

High

279.23

Open

276.91

T/O Rate

1.14%

Low

274.74

Close

276.83

Amplitude

1.62%

Most Discussed

{"pagemeta":{"title":"Beone Medicines Ltd.(688235),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beone Medicines Ltd.(688235) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beone Medicines Ltd.,688235,Beone Medicines Ltd.股票,Beone Medicines Ltd.股票老虎,Beone Medicines Ltd.股票老虎国际,Beone Medicines Ltd.行情,Beone Medicines Ltd.股票行情,Beone Medicines Ltd.股价,Beone Medicines Ltd.股市,Beone Medicines Ltd.股票价格,Beone Medicines Ltd.股票交易,Beone Medicines Ltd.股票购买,Beone Medicines Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beone Medicines Ltd.(688235),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beone Medicines Ltd.(688235) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"688235","data":{"stockData":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"Beone Medicines Ltd.","latestPrice":277.92,"timestamp":1766559601000,"preClose":276.83,"halted":0,"volume":1313519,"delay":0,"changeRate":0.0039,"floatShares":114999999,"shares":1541000000,"eps":-0.0994,"marketStatus":"Closed","change":1.09,"latestTime":"12-24 15:00:01","open":276.91,"high":279.23,"low":274.74,"amount":364000000,"amplitude":0.0162,"askPrice":277.93,"askSize":4,"bidPrice":277.92,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-0.0994,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766626200000},"marketStatusCode":5,"adr":0,"adjPreClose":276.83,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":304.51,"lowLimit":249.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1540677809,"isCdr":false,"pbRate":14.6,"roa":"--","roe":"4.26%","epsLYR":-3.64,"committee":-0.630695,"marketValue":428185000000.0001,"turnoverRate":0.0114,"status":0,"afterMarket":{"amount":0,"volume":0,"close":277.92,"buyVolume":0,"sellVolume":0,"time":1766561639585,"indexStatus":"Closed 12-24 15:30:00","preClose":276.83},"hkstockBrief":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"BEIGENE","latestPrice":183.5,"timestamp":1766549304006,"preClose":184,"halted":0,"volume":1233686,"delay":0,"premium":"-40.50"},"floatMarketCap":31976000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"listingDate":"2021-12-15","address":"c/oBeOneMedicinesIGmbH,Aeschengraben27,4051Basel,Switzerland","stockEarnings":[{"period":"1week","weight":0.0407},{"period":"1month","weight":-0.0074},{"period":"3month","weight":-0.1061},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.7194},{"period":"ytd","weight":0.7192}],"companyName":"百济神州有限公司","boardCode":"AI0027","perCapita":"3195股","boardName":"医药制造业","registeredCapital":"15万元","compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1367},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.1695}],"survey":"　　百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。","serverTime":1766581167738,"listedPrice":192.6,"stockholders":"36008人(较上一季度增加55.74%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}}}}}